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Biosynthesis and intracellular processing of the third component (C3) of complement were studied in cul- 
tured rat hepatocytes. In the control cells, the complement C3 was synthesized as a pro-form, a single poly- 
peptide chain comprising both the c+ and /?-subunits. Although the cleavage of the pro-form into the sub- 
units was not clearly demonstrable within the cells during pulse-chase periods, all the secreted C3 was the 
mature processed form. The cells were treated with secretion-blocking agents with different modes of action, 
colchicine and monensin. Colchicine caused an accumulation of the processed C3 within the cells, whereas 
monensin blocked the secretion without a significant accumulation f the processed form. The results indi- 
cate that the conversion f the C3 pro-form into the subunits takes place in the secretory vesicles just before 
the secretion. 
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1. INTRODUCTION 
The third component of complement, C3, plays 
a central role in the complement system by partici- 
pating in both classical and alternative pathways of 
complement activation [1,2]. The protein is the 
most abundant of all the complement proteins, 
and synthesized mainly in the liver by parenchymal 
cells [3,4], although it is also produced by cells of 
the macrophage/monocyte series [5,6]. C3 isolated 
from plasma is a 187000-dalton glycoprotein 
composed of disulfide-linked LY- and P-chains with 
M, = 115 000 and 75 000, respectively [7]. Recently 
it has been established that C3 is initially synthe- 
sized as single precursor, pro-C3 [4,8], and that 
&chain is the HNz-terminal segment of the pro-C3 
molecule [9,10]. However, it remains to be deter- 
mined where the conversion of pro-C3 to the 
mature form with the subunits takes place during 
the intracellular transport. 
* To whom correspondance and reprint requests should 
be addressed 
The use of drugs affecting the secretory process 
at distinct sites in the cell proves valuable for more 
detailed studies of specific steps in secretion 
[ 1 I, 121. Both the carboxylic ionophore monensin 
[ 11,121 and the anti-microtubular alkaloid colchi- 
tine [13,14] are known to markedly inhibit the 
protein secretion in a variety of cells. Recent obser- 
vations have suggested that monensin blocks the 
transport step from the cis elements to the truns 
elements of the Golgi complex [I 1,12,15], while 
colchicine and other microtubule-affecting agents 
primarily block the secretory process beyond the 
tram Golgi [12,16]. 
Abbreviations: C3, the third component of complement; Here we report the effects of secretion-blocking 
SDS, sodium dodecyl sulfate; PAGE, polyacrylamide agents on the intracellular processing of pro-C3 in 
gel electrophoresis cultured rat hepatocytes, demonstrating that its 
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conversion to the mature form occurs in the secre- 
tory vesicles just before secretion. 
2. MATERIALS AND METHODS 
2.1. Materials 
L-[3’S]Methionine (1150 Ci/mmol) and 
EN3HANCE were purchased from New England 
Nuclear (Boston, MA); colchicine from Merck 
(Darmstadt, FRG); monensin from Calbiochem- 
Behring Corp. (La Jolla, CA); collagenase from 
Wako Junyaku (Osaka, Japan); Eagle’s minimum 
essential medium from Nissui Seiyaku (Tokyo, 
Japan). Goat anti-rat complement C3 antiserum 
was obtained from Cappel Laboratories (West 
Chester, PA). 
2.2. Hepatocyte culture 
Hepatocytes were isolated from adult male 
Wistar rats, weighing 200-25Og, by the collage- 
nase perfusing method of Seglen [17]. Isolated 
hepatocytes were cultured as described previously 
[12,18]. 
2.3. Pulse-chase experiments and immunoprecipi- 
tation 
Cells after being cultured 24 h were preincubated 
at 37°C in the absence or presence of colchicine 
(50/cM) or monensin (laM), pulse-labeled for 
10min with [35S]methionine (100&i/1.5 ml/dish) 
and chased as described previously [12,15]. Each 
drug, when indicated, was present in the medium 
throughout the pulse-chase periods. At the indi- 
cated times, cell lysate and medium were prepared 
and used for immunoprecipitation as described 
previously [12,15]. 
2.4. Polyacrylamide gel electrophoresis 
Sodium dodecyl sulfate (SDS-polyacrylamide 
gel-PAGE) electrophoresis was performed on 
7.5% polyacrylamide slab gels [19]. After electro- 
phoresis, gels were fixed with 30% methanol-10% 
trichloroacetic acid-7% acetic acid for 1 h and 
treated with EN3HANCE, followed by drying and 
fluorography [20]. 
3. RESULTS AND DISCUSSION 
3.1. Time course of secretion of complement C3 
When hepatocytes in control culture were pulse- 
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labeled with [35S]methionine and chased, secretion 
of the labeled C3 started at 30min and reached 
more than 80% of the total labeled C3 by 3 h of 
chase, as shown in fig. 1. The lag time of 30 min for 
C3 secretion is significantly longer than that for 
albumin [12,18], al-protease inhibitor [12,15] and 
haptoglobin [21]; the secretion of the latter three 
proteins started at 10 min under the same condi- 
tions of experiments. When the cells were treated 
with monensin at l,uM, the secretion was com- 
pletely blocked up to 1 h, after that the-protein was 
secreted at a similar rate with that in the control 
cells, reaching about 76% of the normally secreted 
level compared at 3 h of chase. The inhibitory 
effect by colchicine at 50pM was a little weak as 
compared with that by monensin at 1 PM (fig. 1). 
3.2. Analysis of newly synthesized C3 by SDS- 
PAGE electrophoresis 
Immunoprecipitates of intracellular and 
medium C3 prepared from the control cells were 
analyzed by SDS-PAGE followed by fluoro- 
graphy. As shown in fig.2, only a single band was 
observed in the cells throughout pulse-chase 
periods (lanes l-5). Since its apparent molecular 
weight was estimated to be about 190000, this 
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Fig. 1. Time course of secretion of complement C3 in 
primary culture of rat hepatocytes. Hepatocytes were 
pulse-labeled for 10 min with [!%]methionine and chas- 
ed in the absence (0) or presence of colchicine at 50 /cM 
(A) or monensin at 1 PM (0) as described in section 2. 
At the indicated times, immunoprecipitates of the C3 
were prepared from cell lysates and medium, and deter- 
mined for radioactivity. Values are expressed as percen- 
tages of the radioactivity secreted of the total radioac- 
tivity incorporated into the complement C3 during 10 
min pulse. 
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Fig. 2. SDS-page electrophoresis of “S-labeled comple- 
ment C3 synthesized by the control cells. Cells were 
pulse-labeled with [3’S]methionine and chased as shown 
in fig. 1. Immunoprecipitates of C3 prepared from cell 
lysates (lanes 1-5) and medium (lanes 6-9) were sub- 
jected to SDS-PAGE (7.Y70), followed by fluoro- 
graphy. Lane 1, no chase; lanes 2 and 6, chase 30 min; 
lanes 3 and 7, 1 h; lanes 4 and 8, 2 h; lanes 5 and 9, 3 h. 
P, LY and p denote pro-form, u and &subunits, re- 
spectively, of complement C3. 
band corresponds to the pro-form of C3 as 
detected in guinea pig liver [4] and rabbit liver [8]. 
In the medium, by contrast, two major bands cor- 
responding to a-chain (MI = 115 000) and P-chain 
(75 000) were detected at 1 h of chase and accumu- 
lated thereafter (lanes 6-9). No pro-form was 
detectable in the medium. The results demonstrate 
that the newly synthesized complement C3 was 
secreted into the medium after all the pro-form 
was converted to the serum-form with the (Y- and 
P-chains within the cells. It is of interest to note 
that while the conversion of pro-C3 to the serum- 
form had to be completed before secretion, no sig- 
nificant amount of the processed form was detect- 
able in the cells during all the periods of chase 
(fig.2, lanes l-5). This is a contrasting finding as 
compared with the previous results obtained for 
the proalbumin processing, in which the processed 
serum-form was clearly detected within the cells as 
early as 20 min of chase under the same conditions 
employed here [ 16,181. 
3.3. Effects of secretion-blocking agents on the 
processing of pro-C3 
The carboxylic ionophore monensin has been 
demonstrated to block the secretory process at the 
Golgi complex [l 11. We previously reported that 
the drug inhibits not only secretion but also pro- 
teolytic processing of proalbumin [12,15,16] as 
well as terminal glycosylation of the oligosac- 
charide chains of WI-protease inhibitor [12] and 
haptoglobin [21]. On the other hand, the anti- 
microtubular agent colchicine did not significantly 
block these processings but caused an accumula- 
tion of the processed proteins [ 12,181. Taking 
together other available evidence, we have con- 
cluded that monensin exerts its effect by blocking 
the intracellular transport of secretory proteins 
from the cis elements to the trans Golgi, while col- 
chicine primarily blocks the transport from the 
trans Golgi to the cell surface. 
To precisely determine the intracellular conver- 
sion site of pro-C3, we examined the effects of 
monensin and colchicine on the C3 processing. As 
shown in fig. 3A, monensin caused an accumula- 
tion of pro-C3, not the processed form, within the 
cells for a prolonged period of chase (lanes l-5), 
and as a result of delayed secretion there appeared 
in the medium a significant amount of pro-C3 in 
addition to the processed form (lanes 8 and 9), as 
observed in a case of albumin [15]. Treatment of 
the cells with colchicine, for the first time, brought 
about a detectable accumulation of the processed 
form with the a- and&chains in the cells (Fig. 3B, 
lanes 3-5). Based on evidence for the blocking sites 
by the two drugs [ 11,121, these results strongly sup- 
port the conclusion that the conversion of pro-C3 
to the mature form takes place within the secretory 
vesicles just before the secretion. 
Recently Domdey et al. [lo] have reported the 
amino acid sequence of selected domains of the 
mouse C3 molecule which was predicted by 
nucleotide sequence data from cDNA clones. The 
data established the order of subunits in pro-C3 to 
be NHz-,&PCOOH and also indicated the presence 
of four arginine residues located between the 
COOH terminus of the,& and the NH2 terminus of 
the CY subunits in pro-C3 [lo]. Thus, it is likely that 
the proteolytic conversion of pro-C3 to the serum 
form would be initiated by trypsin-like protease, 
followed by removal of arginine residues by car- 
boxypeptidase B-like protease, as commonly 
65 
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Fig. 3. Effects of secretion-blocking agents on intracellular processing of complement C3. Cells were pulse-labeled and 
chased in the presence of monensin (A) or colchicine (B) as shown in fig. 1. Immunoprecipitates of C3 prepared from 
cell lysates (lanes 1-5) and medium (lanes 6-9) were analyzed by SDS-PAGE. Lane 1, no chase; lanes 2 and 6, chase 
30 min; lanes 3 and 7, 1 h; lanes 4 and 8, 2 h; lanes 5 and 9, 3 h. Symbols are the same as in fig. 2. 
observed for proteolytic processing of other pro- 
form proteins [22]. In the hepatocytes, the conver- 
sion of proalbumin to the serum albumin has been 
suggested to be such a case and to occur mainly in 
the secretory vesicles [12,18,23]. It is therefore ex- 
pected that the same proteolytic system in the 
secretory vesicles may function in the conversion 
of both proalbumin and pro-C3, although some 
differences found in kinetics of secretion and con- 
version between the two proteins, as pointed out 
above, remain to be clarified. 
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